Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyâ
2026-03-16ADPT144ROBINS CHAD M plan to sell securities of Adaptive Biotechnologies Corp under Form 144MEDIUM
ROBINS CHAD M filed Form 144 to notify SEC of plan to sell 470167 units of Adaptive Biotechnologies Corp securities around 2026-03-11, with aggregate market value of $6,826,824.84. The total outstanding units is 153981561.0. The amount planned to be sold represents 0.31% of total outstanding units; Recent transactions ...
Mid CapBiotechnology
2026-03-16ADPT144ROBINS HARLAN S plan to sell securities of Adaptive Biotechnologies Corp under Form 144MEDIUM
ROBINS HARLAN S filed Form 144 to notify SEC of plan to sell 470266 units of Adaptive Biotechnologies Corp securities around 2026-03-11, with aggregate market value of $6,828,262.32. The total outstanding units is 153981561.0. The amount planned to be sold represents 0.31% of total outstanding units; Recent transaction...
Mid CapBiotechnology
2026-03-16ADPT144RUBINSTEIN JULIE plan to sell securities of Adaptive Biotechnologies Corp under Form 144MEDIUM
RUBINSTEIN JULIE filed Form 144 to notify SEC of plan to sell 122523 units of Adaptive Biotechnologies Corp securities around 2026-03-11, with aggregate market value of $1,779,033.96. The total outstanding units is 153981561.0. The amount planned to be sold represents 0.08% of total outstanding units; Recent transactio...
Mid CapBiotechnology
2026-03-16MIRM144SAIRA RAMASASTRY plan to sell securities of MIRUM PHARMACEUTICALS, INC. under Form 144MEDIUM
SAIRA RAMASASTRY filed Form 144 to notify SEC of plan to sell 2000 units of MIRUM PHARMACEUTICALS, INC. securities around 2026-03-16, with aggregate market value of $181,520.00. The total outstanding units is 60341617.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in p...
Mid CapBiotechnology